<SEC-DOCUMENT>0001104659-20-052240.txt : 20200428
<SEC-HEADER>0001104659-20-052240.hdr.sgml : 20200428
<ACCEPTANCE-DATETIME>20200428124527
ACCESSION NUMBER:		0001104659-20-052240
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200424
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200428
DATE AS OF CHANGE:		20200428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		20823613

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2017841d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
April 27, 2020 (April 24, 2020)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; padding-top: 2pt; padding-bottom: 2pt; text-align: center">Delaware</TD>
    <TD STYLE="width: 2%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 2pt; padding-bottom: 2pt; text-align: center">001-37392</TD>
    <TD STYLE="width: 2%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 2pt; padding-bottom: 2pt; text-align: center">95-4472349</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center">(State or Other Jurisdiction</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center">(Commission File</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center">(I.R.S. Employer</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center">of Incorporation)</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center">Number)</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center">Identification Number)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1668 S. Garfield Avenue, 2nd Floor, Alhambra,
CA 91801</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(626) 282-0288</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">N/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Precommencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Precommencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 35%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center">Title of each class</TD>
    <TD STYLE="width: 30%; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center">Trading Symbol(s)</TD>
    <TD STYLE="width: 35%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center">Name of each exchange on which registered</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center">Common Stock</TD>
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center">AMEH</TD>
    <TD STYLE="border: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center">Nasdaq Capital Market</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR &sect;240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 4.01</B></TD><TD STYLE="text-align: justify"><B>Changes in Registrant&rsquo;s Certifying Accountant.</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">On
April&nbsp;24, 2020, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">following a competitive selection process</FONT><FONT STYLE="background-color: white">,
the Audit Committee of the Board of Directors of Apollo Medical Holdings, Inc. (the &ldquo;Company&rdquo;) approved the engagement
of Ernst &amp; Young LLP (&ldquo;E&amp;Y&rdquo;) as the Company&rsquo;s independent registered public accounting firm for the fiscal
year ending December&nbsp;31, 2020 and approved the dismissal of BDO USA, LLP (&ldquo;BDO&rdquo;) from service as the Company&rsquo;s
independent registered public accounting firm, effective immediately. The Company engaged E&amp;Y on April&nbsp;27, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal year
ended December 31, 2019 and December 31, 2018 and through the subsequent interim period through April 24, 2020, there were (i)
no disagreements (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company
and BDO on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which,
if not resolved to the satisfaction of BDO would have caused BDO to make reference thereto in its reports on the consolidated financial
statements of the Companies for such years, and (ii) no &ldquo;reportable events&rdquo; (as that term is defined in Item 304(a)(1)(v)
of Regulation S-K), except for a material weakness identified in the Company&rsquo;s internal control over financial reporting
related to the review of completeness and accuracy of data included in the full risk pool reports provided by an external party
based on which material amounts of revenue were recognized. The Company identified and disclosed this material weakness in Management&rsquo;s
Annual Report on Internal Control Over Financial Reporting in Item 9A of the Company&rsquo;s Annual Report on Form 10-K for the
year ended December 31, 2018, which it filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on March 18, 2019,
and subsequently remediated the material weakness on December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company provided
BDO with a copy of this Current Report on Form 8-K and requested that BDO provide the Company with a letter addressed to the SEC
stating whether or not BDO agrees with the above disclosures. A copy of BDO&rsquo;s letter, dated April 27, 2020, is attached as
Exhibit 16.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal years
ended December 31, 2019 and December 31, 2018 and through the subsequent interim period through April 27, 2020, neither the Company,
nor any party on its behalf, consulted with E&amp;Y with respect to either (i) the application of accounting principles to a specified
transaction, either completed or proposed, or the type of the audit opinion that might be rendered with respect to the Company&rsquo;s
consolidated financial statements, and no written report or oral advice was provided by E&amp;Y to the Company that was an important
factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any
matter that was subject to any disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions)
or a reportable event (as that term is defined in Item 304(a)(1)(v) of Regulation S-K).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 9.01</B></TD><TD STYLE="text-align: justify"><B>Financial Statements And Exhibits</B></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Exhibits.</TD>
</TR></TABLE>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 11%; border-bottom: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><B>Exhibit
    No.</B></TD>
    <TD STYLE="width: 3%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="width: 86%; border-bottom: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><B>Description</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: center"><A HREF="tm2017841d1_ex16-1.htm" STYLE="-sec-extract: exhibit">16.1</A></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><A HREF="tm2017841d1_ex16-1.htm" STYLE="-sec-extract: exhibit">Letter, dated April 27, 2020, from BDO USA, LLP to the Securities and Exchange
    Commission.</A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 50pt">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><B>APOLLO MEDICAL HOLDINGS, INC.</B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 50%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 5%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 30%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 15%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">Dated: April 27, 2020</TD>
    <TD STYLE="padding: 0; text-indent: 0">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding: 0; text-indent: 0">/s/ Thomas S. Lam, M.D.</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Name:</TD>
    <TD STYLE="padding: 0; text-indent: 0">Thomas S. Lam, M.D.</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Title:</TD>
    <TD STYLE="padding: 0; text-indent: 0">Co-Chief Executive Officer</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>tm2017841d1_ex16-1.htm
<DESCRIPTION>EXHIBIT 16.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 16.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="3" STYLE="padding: 0; width: 50%; text-indent: 0"><IMG SRC="image_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="padding: 0; width: 25%; text-indent: 0">Tel:&nbsp;&nbsp;310-557-0300</TD>
    <TD STYLE="padding: 0; width: 25%; text-indent: 0">515 S Flower St, 47th Floor</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">Fax:&nbsp;&nbsp;310-557-1777</TD>
    <TD STYLE="padding: 0; text-indent: 0">Los Angeles, CA 90071</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><B>www.bdo.com</B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 27, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have been furnished with a copy of the response to Item 4.01
of Form 8-K for the event that occurred on April 24, 2020, to be filed by our former client, Apollo Medical Holdings, Inc. We agree
with the statements made in response to that Item insofar as they relate to our Firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>



<P STYLE="margin: 0; text-align: left"><B></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B><IMG SRC="image_002.jpg" ALT="">&nbsp;&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  W 'X# 2(  A$! Q$!_\0
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M ,+>M/\ H%S_ /?0H_X6]:?] N?_ +Z%7/,[QY86BO(2X>QU[NFW\U_F>DD
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M#%_\_9?>P_X5SX4_Z!7_ ),2_P#Q5'_"N?"G_0*_\F)?_BJ**.2/8/[0Q?\
MS]E][#_A7/A3_H%?^3$O_P 5726MM#96L-K;ILAA01HN2<*!@#)YZ"BBFHI;
..(RJXFM6256;E;NVS_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S *X# 2(  A$! Q$!_\0
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MLD>XKD9SU'(Y H @\,DMX4T=BI4FQAX/4?(*U:CMX(K6VBMX$V11($11V4#
M'Y5)0 4444 %%%% !1110 4444 %%%% !1110 4444 % &!@=*** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
